Targeting the multifaceted BRAF in cancer: New directions

Read Full Article

#BRAF #CancerResearch #PrecisionMedicine #TherapeuticTargets #OncologyTreatment

NYU develops new drug that attacks cancer cells without harming healthy ones by developing antibodies that recognize only mutant HER2 in human cell lines and in mouse models | Researchers say the technique may lead to new ways to treat patients with some cancers with minimal side effects.

Read Full Article

#NYUResearch #CancerTreatment #HER2Antibodies #PrecisionMedicine #InnovativeHealthcare

Scientists have uncovered functionality of a genetic variant in the prostate specific antigen (PSA) gene to improve the current diagnostic test to help distinguish aggressive from non-aggressive prostate cancers and the level of treatment the patient need

Read Full Article

#ProstateCancer #GeneticVariant #PSAgene #CancerResearch #PrecisionMedicine

Scientists successfully control when genetically engineered non-toxic bacteria, after intravenously injected, invades cancer cells and delivers cancer-fighting drugs directly into tumors in mouse models, sparing healthy tissue, and delivering more therapy as the bacteria grow in the tumors.

Read Full Article

#CancerResearch #GeneEngineering #TargetedTherapy #PrecisionMedicine #BiomedicalInnovation

A Cell study on pediatric cancer reveals how age and tumor type shape immune responses. T cell activity and inflammation correlate with mutation rates. Findings aim to advance precision immunotherapy, improving treatment for children with cancer.

Read Full Article

#PediatricCancer #Immunotherapy #CancerResearch #TCellActivity #PrecisionMedicine

Scientists at Columbia have developed a CRISPR base editing approach for gene variant classification in a rare immune disorder 🧬, enabling precision therapy treatment for a patient 💉.

Read Full Article

#CRISPR #GeneEditing #PrecisionMedicine #ImmuneDisorder #MedicalResearch

Scientists found that nearly every cancer harbors its own distinct community of microbes 🦠 – the tumor microbiome 🧬 – that can influence how tumors start, spread, and respond to treatment, paving the way for a new era of precision medicine 💊.

Read Full Article

#CancerResearch #TumorMicrobiome #PrecisionMedicine #HealthInnovation #MicrobiomeScience

☕️ Texas A&M researchers are using caffeine with CRISPR gene-editing technology to develop new treatments for diseases like cancer and diabetes.

🧪 This new chemogenetic approach, dubbed "caffebodies," allows for precise control over gene expression by activating engineered switches in cells with a 20 mg dose of caffeine.

🔄 The process can be reversed using drugs like rapamycin, offering clinicians reversible control over gene modification for safer therapies.

🔬 This technology shows promise for directing the immune system against tumors and potentially enabling patients with diabetes to boost insulin production simply by consuming caffeine.

#GeneEditing #PrecisionMedicine #Biotechnology

Targeting the immune system may help treat a specific subtype of depression. Study found that when patients are selected based on elevated inflammation markers, certain drugs reduce both general depressive symptoms and the inability to feel pleasure.

Read Full Article

#immune #depression #inflammation #biomarkers #precisionmedicine

✅ New research suggests anti-inflammatory drugs may effectively treat depression, but only for individuals with an overactive immune system, identified by elevated inflammation markers.

✅ A review of 11 trials (321 participants) found these treatments reduced general depressive symptoms and anhedonia (inability to feel pleasure) compared to placebo in this specific group.

✅ The study highlights the need for precision medicine in mental health, moving away from "one-size-fits-all" approaches. C-reactive protein levels could potentially identify patients who might benefit.

✅ While generally safe in short-term trials (2-12 weeks), researchers emphasize the need for larger, confirmatory studies and a better understanding of underlying immune mechanisms for long-term treatment.

#DepressionResearch #MentalHealth #PrecisionMedicine

The Millisecond That Could Change Cancer Treatment

Read Full Article

#CancerResearch #PrecisionMedicine #MilisecondBreakthrough #EarlyDetection #OncologyInnovation

A team of scientists from Manchester and London have, for the first time, decoded the full range of mutations that drive tumour growth, which could pave the way for a new era in precision medicine, offering more effective treatments for thousands of people with cancer.

Read Full Article

#CancerResearch #PrecisionMedicine #Genomics

🔬 UK scientists have mapped 370 million genetic mutations across 16 cancer types, identifying 134 "mutational signatures" that act like fingerprints of cancer causes.

🧬 This groundbreaking research, published in Nature Genetics, analyzed nearly 11,000 NHS patient tumors and could expand eligibility for precision therapies, potentially helping over 7,700 UK breast cancer patients and 1,000 ovarian cancer patients with homologous recombination deficiency (HRD).

🦠 The study also found evidence supporting the theory that toxins from certain E. coli strains may contribute to early-onset bowel cancer, as the associated signature was more prevalent in younger patients.

#CancerResearch #Genomics #PrecisionMedicine

🔬 New Study Reveals Sex-Specific Immune System Aging
Supercomputing analysis of 20,000 genes in over 1 million cells shows distinct aging patterns between men and women, a breakthrough for precision medicine. Previously, many immune aging characteristics were thought to be universal but are now shown to differ by biological sex.

🔬 Key Sex Differences in Immune Function Identified
Statistics indicate men are more prone to infections and cancers, while women have stronger immune responses, including better vaccine reactions. However, women's more reactive systems increase their risk of autoimmune diseases, accounting for 80% of cases.

🔬 BSC-CNS Study Details Molecular Basis of Differences
Published in Nature Aging, the Barcelona Supercomputing Center (BSC-CNS) study identifies specific cells and genes driving these sex-based immunological aging dynamics, providing a molecular explanation for observed population-level differences.

🔬 Implications for Precision Medicine and Health
Results show women experience more significant immune changes with age, including increased inflammatory cells, potentially explaining higher rates of autoimmune diseases and inflammatory conditions post-menopause. Men exhibit less extensive aging changes but an increase in blood cells with pre-leukemia alterations, possibly linked to higher blood cancer rates.

#PrecisionMedicine #Immunosenescence #HealthTech

🔬 Scientists have identified over 1000 genetic switches that function differently in female and male immune cells, explaining why women are more prone to autoimmune diseases.

🔬 The study, published in The American Journal of Human Genetics, utilized single-cell technology to analyze over 1.25 million immune cells from nearly 1000 individuals.

🔬 Researchers discovered that while female immune systems are better at fighting viral infections due to higher inflammatory activity, this also makes them more susceptible to mistakenly attacking the body's own tissues.

🔬 These findings suggest that autoimmune diseases may present differently in men and women, highlighting the need for sex-specific medical research and tailored treatments.

#ImmuneSystem #AutoimmuneDisease #PrecisionMedicine

Gene test could spare patients from unnecessary chemotherapy

Read Full Article

#GeneticTesting #PrecisionMedicine #ChemotherapyAlternatives

🔬 New study from Mass General Brigham Cancer Institute shows HPV-DeepSeek blood test can identify patients with HPV-associated head and neck cancer who may need further treatment after surgery.

📊 The Clear-HPVca study followed 103 patients between August 2020 and March 2024. After surgery, 23% had detectable circulating tumor HPV DNA, and these patients had significantly worse outcomes, with only 60% disease-free at two years compared to 100% of those with negative tests.

⏱️ HPV-DeepSeek detected cancer recurrence an average of seven months earlier than traditional methods and existing HPV DNA blood tests, potentially offering a longer lead time for intervention.

💡 Researchers believe this ultrasensitive test could lead to more personalized treatment plans, moving beyond general risk factors to tailor care based on individual cancer biology.

#CancerResearch #HeadAndNeckCancer #PrecisionMedicine

🔬 New research published today in Nature reveals the first direct evidence that our inherited genes significantly influence cancer risk by interacting with acquired mutations to shape tumor evolution.

🧬 The study, conducted in mice, demonstrates that genetic background can alter how tumors develop and evolve, suggesting personalized cancer prevention and screening strategies may need to consider inherited genetics and population diversity.

💊 Findings indicate that responses to cancer treatments could vary based on a patient's genetic makeup, strengthening the argument for tailored treatment approaches.

#CancerResearch #Genetics #PrecisionMedicine